Electrochemotherapy of mucosal head and neck tumors: a systematic review

References

• Stewart BW, Wild CP. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer; 2014. pp. 632.
   Google Scholar
• Mir LM, Orlowski S, Belehradek J, et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991;27:68–72.
   PubMed Web of Science ®Google Scholar
• Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1993;1154:51–63.
   PubMed Web of Science ®Google Scholar
• Mir LM, Banoun H, Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988;175:15–25.
   PubMed Web of Science ®Google Scholar
• Mir LM. Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 2001;53:1–10.
   PubMed Web of Science ®Google Scholar
• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003;29:371–87.
   PubMed Web of Science ®Google Scholar
• Mir LM, Tounekti O, Orlowski S. Bleomycin: revival of an old drug. Gen Pharmacol 1996;27:745–8.
   PubMedGoogle Scholar
• Tounekti O, Pron G, Belehradek J, et al. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 1993;53:5462–9.
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anticancer Drugs 1998;9:319–25.
   PubMed Web of Science ®Google Scholar
• Orlowski S, Belehradek J, Paoletti C, et al. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727–33.
   PubMed Web of Science ®Google Scholar
• Marty M, Sersa G, Garbay JR, et al. Electrochemotherapy - An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European standard operating procedures of electrochemotherapy) study. Eur J Cancer 2006;4:3–13.
   Web of Science ®Google Scholar
• Matthiessen LW, Chalmers RL, Sainsbury DCG, et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011;50:621–9.
   PubMed Web of Science ®Google Scholar
• Belehradek M, Domenge C, Luboinski B, et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993;72:3694–700.
   PubMed Web of Science ®Google Scholar
• Mir LM, Belehradek M, Domenge C, et al. [Electrochemotherapy, a new antitumor treatment: first clinical trial]. C R Acad Sci III Sci Vie 1991;313:613–18.
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 1996;77:964–71.
   PubMed Web of Science ®Google Scholar
• Glass LF, Pepine ML, Fenske NA, et al. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996;132:1353–7.
   PubMed Web of Science ®Google Scholar
• Heller R, Jaroszeski MJ, Reintgen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998;83:148–57.
   PubMed Web of Science ®Google Scholar
• Rols MP, Bachaud JM, Giraud P, et al. Electrochemotherapy of cutaneous metastases in malignant melanoma. Melanoma Res 2000;10:468–74.
   PubMed Web of Science ®Google Scholar
• Matthiessen LW, Johannesen HH, Hendel HW, et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 2012;51:713–21.
   PubMed Web of Science ®Google Scholar
• Garbay JR, Billard V, Bernat C, et al. Successful repetitive treatments by electrochemotherapy of multiple unresectable Kaposi sarcoma nodules. Eur J Cancer 2006;4:29–31.
   Web of Science ®Google Scholar
• Spratt DE, Gordon Spratt EA, Wu S, et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 2014;32:3144–55.
   PubMed Web of Science ®Google Scholar
• Scala D, Rega D, Ruffolo F, et al. Electrochemotherapy for rectal cancer after neoadjuvant radiotherapy: a case report. Eur J Surg Oncol 2015;41:S13–14.
   Google Scholar
• Edhemovic I, Brecelj E, Gasljevic G, et al. Intraoperative electrochemotherapy of colorectal liver metastases. J Surg Oncol 2014;110:320–7.
   PubMed Web of Science ®Google Scholar
• Frandsen SK, Gissel H, Hojman P, et al. Direct therapeutic applications of calcium electroporation to effectively induce tumor necrosis. Cancer Res 2012;72:1336–41.
   PubMed Web of Science ®Google Scholar
• Vásquez JL, Ibsen P, Lindberg H, et al. In vitro and in vivo experiments on electrochemotherapy for bladder cancer. J Urol 2015;193:1009–15.
   PubMed Web of Science ®Google Scholar
• Gothelf A, Gehl J. What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother 2012;8:1694–702.
   PubMed Web of Science ®Google Scholar
• Gehl J. Gene electrotransfer in clinical trials. Electroporation protocols. In: Li S, Cutrera J, Heller R, et al., editors. Methods in molecular biology. (Clifton, NJ). New York, NY: Springer New York; 2014. pp. 241–6.
   Google Scholar
• Mir LM, Gehl J, Sersa G, et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or noninvasive electrodes. Eur J Cancer Suppl 2006;4:14–25.
   Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010;8:336–41.
   PubMed Web of Science ®Google Scholar
• Allegretti JP, Panje WR. Electroporation therapy for head and neck cancer including carotid artery involvement. Laryngoscope 2001;111:52–6.
   PubMed Web of Science ®Google Scholar
• Bloom DC, Goldfarb PM. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2005;31:1029–35.
   PubMed Web of Science ®Google Scholar
• Burian M, Formanek M, Regele H. Electroporation therapy in head and neck cancer. Acta Otolaryngol 2003;123:264–8.
   PubMed Web of Science ®Google Scholar
• Campana LG, Mali B, Sersa G, et al. Electrochemotherapy in non-melanoma head and neck cancers: a retrospective analysis of the treated cases. Br J Oral Maxillofac Surg 2014;52:957–64.
   PubMed Web of Science ®Google Scholar
• Gargiulo M, Papa A, Capasso P, et al. Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients. Ann Surg 2012;255:1158–64.
   PubMed Web of Science ®Google Scholar
• Landström FJ, Reizenstein J, Adamsson G-B, et al. Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx. Acta Otolaryngol 2015;135:1070–8.
   PubMed Web of Science ®Google Scholar
• Landström FJ, Reizenstein JA, Nilsson COS, et al. Electrochemotherapy - possible benefits and limitations to its use in the head and neck region. Acta Otolaryngol 2015;135:90–5.
   PubMed Web of Science ®Google Scholar
• Mevio N, Bertino G, Occhini A, et al. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results. Tumori 2012;98:308–13.
   PubMed Web of Science ®Google Scholar
• Seccia V, Muscatello L, Dallan I, et al. Electrochemotherapy and its controversial results in patients with head and neck cancer. Anticancer Res 2014;34:967–72.
   PubMed Web of Science ®Google Scholar
• Skarlatos I, Kyrgias G, Mosa E, et al. Electrochemotherapy in cancer patients: first clinical trial in Greece. In Vivo 2011;25:265–74.
   PubMed Web of Science ®Google Scholar
• Tijink BM, De Bree R, Van Dongen GAMS, et al. How we do it: chemo-electroporation in the head and neck for otherwise untreatable patients. Clin Otolaryngol 2006;31:447–51.
   PubMed Web of Science ®Google Scholar
• Gargiulo M, Moio M Monda G, et al. Electrochemotherapy: actual considerations and clinical experience in head and neck cancers. Ann Surg 2010;251:773.
   PubMed Web of Science ®Google Scholar
• Hofmann GA, Dev SB, Dimmer S, et al. Electroporation therapy: a new approach for the treatment of head and neck cancer. IEEE Trans Biomed Eng 1999;46:752–9.
   PubMed Web of Science ®Google Scholar
• Panje WR, Sadeghi N. Endoscopic and electroporation therapy of paranasal sinus tumors. Am J Rhinol 2000;14:187–91.
   PubMedGoogle Scholar
• Panje WR, Hier MP, Garman GR, et al. Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol 1998;107:779–85.
   PubMed Web of Science ®Google Scholar
• Landström FJ, Nilsson COS, Reizenstein JA, et al. Electroporation therapy for T1 and T2 oral tongue cancer. Acta Otolaryngol 2011;131:660–4.
   PubMed Web of Science ®Google Scholar
• Campana LG, Bertino G, Rossi CR, et al. The value of electrochemotherapy in the treatment of peristomal tumors. Eur J Surg Oncol 2014;40:260–2.
   PubMed Web of Science ®Google Scholar
• Wojcicki M, Kostyrka R, Kaczmarek B, et al. Electrochemical therapy in palliative treatment of malignant dysphagia: a pilot study. Hepatogastroenterology 1999;46:278–84.
   PubMed Web of Science ®Google Scholar
• Eisenhauer E. a, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Matthiessen LW, Curatolo P, et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol 2015;54:298–306.
   PubMed Web of Science ®Google Scholar